Specifica

Specifica is dedicated to enhancing companies with the power to create cures through visionary antibody technologies. Antibody libraries are a source for generating therapeutic antibodies using phage or yeast display. Specifica’s Generation 3 platform enables the direct generation of antibody-like drugs from naïve libraries, offering broad diversity, high affinity, and minimal biophysical liabilities. In addition to internal projects, Specifica also works closely with partners to create customized libraries, optimizing key elements according to the partners' needs.